Fibrosis: types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation

SA Antar, NA Ashour, ME Marawan… - International Journal of …, 2023 - mdpi.com
Most chronic inflammatory illnesses include fibrosis as a pathogenic characteristic.
Extracellular matrix (ECM) components build up in excess to cause fibrosis or scarring. The …

Inflammation: a putative link between phosphate metabolism and cardiovascular disease

J Voelkl, D Egli-Spichtig, I Alesutan… - Clinical Science, 2021 - portlandpress.com
Dietary habits in the western world lead to increasing phosphate intake. Under physiological
conditions, extraosseous precipitation of phosphate with calcium is prevented by a mineral …

Therapeutic targets for heart failure identified using proteomics and Mendelian randomization

A Henry, M Gordillo-Marañón, C Finan, AF Schmidt… - Circulation, 2022 - Am Heart Assoc
Background: Heart failure (HF) is a highly prevalent disorder for which disease mechanisms
are incompletely understood. The discovery of disease-associated proteins with causal …

Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox

ZX Wang, ZW Luo, FXZ Li, J Cao, SS Rao… - Nature …, 2022 - nature.com
Adipocyte differentiation of bone marrow mesenchymal stem/stromal cells (BMSCs) instead
of osteoblast formation contributes to age-and menopause-related marrow adiposity and …

FGF23 and phosphate–cardiovascular toxins in CKD

I Vogt, D Haffner, M Leifheit-Nestler - Toxins, 2019 - mdpi.com
Elevated levels of fibroblast growth factor 23 (FGF23) and phosphate are highly associated
with increased cardiovascular disease and mortality in patients suffering from chronic kidney …

The role of fibroblast growth factor 23 in inflammation and anemia

B Czaya, C Faul - International journal of molecular sciences, 2019 - mdpi.com
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …

ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease

L Ouyang, X Su, W Li, L Tang, M Zhang… - The Journal of …, 2021 - Am Soc Clin Investig
Vascular calcification (VC) predicts cardiovascular morbidity and mortality in chronic kidney
disease (CKD). To date, the underlying mechanisms remain unclear. We detected leukocyte …

Osteocytic FGF23 and its kidney function

R Agoro, P Ni, ML Noonan, KE White - Frontiers in endocrinology, 2020 - frontiersin.org
Osteocytes, which represent up to 95% of adult skeletal cells, are deeply embedded in bone.
These cells exhibit important interactive abilities with other bone cells such as osteoblasts …

Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease

C Yanucil, D Kentrup, I Campos, B Czaya, K Heitman… - Kidney international, 2022 - Elsevier
Fibroblast growth factor (FGF) 23 is a phosphate-regulating hormone that is elevated in
patients with chronic kidney disease and associated with cardiovascular mortality …

The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials

A Zittermann, HK Berthold, S Pilz - European Journal of Clinical …, 2021 - nature.com
The phosphaturic hormone fibroblast growth factor 23 (FGF23) is a risk marker of
cardiovascular and all-cause mortality. We therefore aimed to synthesize the evidence for …